1158 related articles for article (PubMed ID: 24307777)
1. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
2. [Research advances in diagnostic and therapeutic application of long-chain non-coding RNAs in hepatocellular carcinoma].
Li WX; Li Q; Lin Y; Huang YX; Chen L
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):628-631. PubMed ID: 27788714
[TBL] [Abstract][Full Text] [Related]
3. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma.
Plissonnier ML; Herzog K; Levrero M; Zeisel MB
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380697
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
7. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.
Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y
Front Immunol; 2024; 15():1400744. PubMed ID: 38799446
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
[TBL] [Abstract][Full Text] [Related]
10. LncRNAs in HCV Infection and HCV-Related Liver Disease.
Unfried JP; Fortes P
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32214045
[TBL] [Abstract][Full Text] [Related]
11. Complex interactions between microRNAs and hepatitis B/C viruses.
Fan HX; Tang H
World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
[TBL] [Abstract][Full Text] [Related]
13. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
Eguchi H; Doki Y; Mori M
Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
[TBL] [Abstract][Full Text] [Related]
14. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.
Khashkhashi Moghadam S; Bakhshinejad B; Khalafizadeh A; Mahmud Hussen B; Babashah S
J Cell Mol Med; 2022 Jan; 26(2):287-305. PubMed ID: 34907642
[TBL] [Abstract][Full Text] [Related]
16. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma.
Wong LS; Wong CM
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808647
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
Wong CM; Tsang FH; Ng IO
Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
